Market Trends– category –
-
Market Trends
openPR Report: Perovskite Solar Cell Market Enters Commercial Scale-Up Phase in 2026, Projected to Reach $32.44 Billion by 2033
openPR.com Unknown Overview This article outlines a report distributed via openPR.com, indicating the perovskite solar cell market has entered a commercial scale-up phase in 2026, with an estimated value of $810.6 million. The market is ... -
Market Trends
Monochrome Initiates High-Altitude Field Testing of Perovskite Solar Modules in Pakistan’s Karakoram Range at 5150m
pv magazine Global Japan Overview Monochrome commenced field testing of a perovskite PV prototype at approximately 5,150 meters altitude during a high-altitude expedition in Pakistan's Karakoram range. This test will evaluate power gener... -
Market Trends
Perovskite-Silicon Tandem Cells Achieve 34.85% Efficiency, Mass Adoption Expected by 2027-2028, Driving Global Solar Trends in 2026
GreenLancer USA Overview Perovskite-silicon tandem cells achieved 34.85% efficiency in 2026, surpassing conventional silicon panels' theoretical limits, marking a significant advancement in solar technology. Oxford PV shipped the world's... -
Market Trends
Dexcom’s Investment Outlook Brightens as G7 CGM Gains Expanded Reimbursement for Type 2 Non-Insulin Diabetes Patients
Seeking Alpha USA Overview Dexcom's investment thesis has significantly improved following expanded insurance reimbursement for its G7 continuous glucose monitoring (CGM) systems, now covering a large population of type 2 non-insulin dia... -
Market Trends
CNET Reviews 2026’s Latest Continuous Glucose Monitors (CGM), Highlighting FDA-Approved Dexcom Stelo’s Integration with Oura Ring
CNET USA Overview CNET's 2026 review of Continuous Glucose Monitors (CGM) features Abbott Freestyle Libre 2 and 3 Plus, Dexcom G7, and the notable Stelo by Dexcom, the first FDA-approved over-the-counter CGM in the US (2024). Stelo's sea... -
Market Trends
Abbott Submits Dual Glucose-Ketone Sensor ‘Libre Duo’ to US FDA for DKA Prevention After European CE Mark
MedTech Dive USA Overview Abbott has filed an FDA application to launch its dual glucose-ketone sensor, Libre Duo, in the U.S. after receiving Europe's CE mark. Approval is expected by year-end, with the device aiming to prevent diabetic... -
Market Trends
ThePrint Reports Biosensors and Microfluidics Cut Foodborne Pathogen Detection from Days to Minutes, Accelerating Food Safety Across Supply Chain
ThePrint India Overview ThePrint reports technological advancements in food safety diagnostics leveraging biosensors and microfluidics to rapidly detect foodborne pathogens like Salmonella and E. coli in minutes, rather than days. These ... -
Market Trends
Forge Nano Breaks Ground on ‘America’s Battery Gigafactory’ in North Carolina, Bolstering U.S. Defense Supply Chains with 3GWh Annual Capacity
Fidelity Investments (PR Newswire) USA Overview Forge Nano has commenced construction of 'America's Battery Gigafactory' in Morrisville, North Carolina, aiming for an annual domestic battery production capacity of up to 3GWh. This projec... -
Market Trends
National Science Foundation Leads Nanotechnology Investment with 147 Rounds in U.S., Acquirezy Reports Active Funding & M&A
Acquirezy USA Overview Acquirezy's report highlights robust investment in the U.S. nanotechnology sector, identifying the National Science Foundation (NSF) as the most active investor with 147 funding rounds. Notable companies like Ilika... -
Market Trends
First Graphene Scales Up: 100-Ton PureGRAPH Production and European REACH Compliance Signal Industrial Breakthrough
Proactive Australia Overview Australian advanced materials firm First Graphene is significantly advancing the commercialization of its industrial-grade PureGRAPH graphene, establishing a 100-ton annual production capacity. With comprehen...